• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Stablecoin Tether says holds no Evergrande commercial paper

September 16, 2021 by David Barret Leave a Comment

September 16, 2021

HONG KONG (Reuters) – Tether, the world’s largest ‘stablecoin’, said in a statement it does not hold any commercial paper or securities issued by embattled developer China Evergrande Group, as regulatory scrutiny into risks from this type of token grow.

Evergrande, which has total liabilities of more than $300 billion, is also in the spotlight as it scrambles to raise funds, teetering between a messy meltdown with far-reaching impacts, a managed collapse or a government bailout.

“Tether does not hold any commercial paper or other debt or securities issued by Evergrande and has never done so,” the company said.

“The vast majority of the commercial paper held by Tether is in A-2 and above rated issuers.”

Regulators are starting to pay greater attention to stablecoins – digital tokens which are pegged in value to other assets, often the U.S. dollar, and backed by a pool of assets – and some observers have raised concerns about the tokens’ liquidity in a time of stress.

Approximately half of Tether’s $62.8 billion assets as of the end of June 2021, were backed by commercial paper and certificates of deposit, according to the company.

Evergrande’s main unit had 205.7 billion yuan ($32 billion) worth of commercial paper at the end of 2020, filings show.

The developer on Thursday applied to suspend trading of that unit’s onshore corporate bonds following a downgrade, which market participants said indicated an increasing likelihood of defaults and restructuring.

(Reporting by Alun John; Editing by Mark Potter)

Source Link Stablecoin Tether says holds no Evergrande commercial paper

David Barret
David Barret

Related posts:

  1. Exclusive-Dubai courier Aramex in talks to buy Turkey’s MNG Kargo -sources
  2. UK regulators tell trade finance firms to step up crime controls
  3. Exclusive-Singapore’s ADVANCE.AI raising $200 million from Warburg Pincus-led investors – sources
  4. ECB trims emergency support but insists “no tapering”

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • You Can Watch 1.8 Billion Years Of Earth’s Tectonic Plates Shifting In This 1-Minute Video
  • Achoo! Why Do People Say “Bless You” When You Sneeze?
  • Could Studying Dinosaurs’ Cancer Help Us Cure Our Own?
  • 95 Percent Of The World’s Youngest, Smallest, And Most Mysterious Continent Is Underwater
  • Physics Puzzle Of The Week: Why Won’t This Contraption Turn?
  • This Sea Snake Only Lives In One Place On Earth – And It’s Not The Sea
  • Child From World’s Oldest Burial Was Neanderthal-Homo Sapiens Hybrid
  • Why A Green Roof Could Protect You Against Microplastics From The Atmosphere
  • A Language Without Numbers? Pirahã Challenges Long-Held Theories Of Linguistics
  • World-First Livestream Reveals Secret Lives Of Greater Gliders, Including Never-Before-Seen Behaviors
  • Olympus Mons: The Biggest Volcano In The Solar System Makes Mount Everest Look Like A Hillock
  • DARPA Sends Energy Wirelessly Over 8.6 Kilometers, Setting A New World Record
  • “Anomalous” Radio Pulses Detected In Antarctica Are Coming From Underneath The Ice
  • Sharing Cute Animal Pics With Your Pals Might Actually Serve An Important Purpose
  • Solar Eclipses On Command? That’s Now A Reality
  • First-Of-Its-Kind GPS Data Reveals Egret’s Incredible 38-Hour, Non-Stop Flight From Australia To Papua New Guinea
  • Meet The Pearlfish That Calls Sea Cucumbers’ Butts Home And Can Reverse Park Into Tight Spaces
  • 10 Teeny Tiny Chevrotains: Meet The Smallest Hoofed Mammals On Earth
  • Lab-Grown Salmon Receives FDA Approval In The US, The First Cultivated Seafood To Do So
  • Sharks Have To Keep Swimming, Or Else They’ll Die? Well, No, Not Really
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version